UKHSA (UK) · Jul 14, 2026
Research: Chikungunya: epidemiology in England, Wales and Northern Ireland
Epidemiological data on chikungunya cases in England, Wales and Northern Ireland.
Latest medical news · page 73
The latest headlines across every section, pulled from official and open-access sources.
UKHSA (UK) · Jul 14, 2026
Research: Laboratory-confirmed dengue cases: statistics
Epidemiological data on laboratory-confirmed dengue cases in England, Wales and Northern Ireland.
UKHSA (UK) · Jul 14, 2026
Correspondence: Pneumococcal vaccination: expansion of eligibility to people experiencing homelessness
Information on the inclusion of people experiencing homelessness (PEH) as a new clinical risk group eligible for pneumococcal vaccination from 1 October 2026.
DHSC (UK) · Jul 14, 2026
Millions of unpaid carers to get recognition and earlier support
First ever cross-government action plan to support unpaid carers published.
MedCity News · Jul 14, 2026
Kaiser Nurses Protest CEO’s AHA Appearance Over AI Concerns
As Kaiser Permanente CEO Greg Adams touted the success of his organization’s value-based care models at the AHA Leadership Summit in Denver, Kaiser nurses outside protested the health system’s AI strategy. They claim they’re being excluded from decisions about the technology. The post Kaiser Nurses Protest CEO’s AHA Appearance Over AI Concerns appeared first on MedCity News .
CDC Emerging Infections · Jul 14, 2026
Outbreak of Hepatitis A Linked to Frozen Blueberries, the Netherlands, 2024–2025
I. Friesema et al.
FDA MedWatch · Jul 14, 2026
Positive Pressure Breathing Device Correction: Baxter Issues Correction for Volera Positive Pressure Breathing Devices
Volara system patient circuits may leak air and medication from the nebulizer cup during therapy, leading to reduced oxygenation and ineffective nebulization.
CDC Emerging Infections · Jul 14, 2026
Respiratory Syncytial Virus Suppression through Public Health and Social Measures, Hong Kong, China, 2020–2023
Y. Xu et al.
Fierce Biotech · Jul 14, 2026
‘Neural tourniquet’ device could hold key to stopping life-threatening hemorrhage
An ear-based wearable device that taps into the body’s longest cranial nerve boosts blood clotting, which researchers hope could be a new way to treat severe bleeding.
Fierce Biotech · Jul 14, 2026
Avere goes public via NextCure reverse merger, secures Hansoh IL-23 drug with $2.3B deal
Avere Therapeutics has burst onto the scene by securing a public listing via a reverse merger with NextCure, while stocking a pipeline with an IL-23 drug from Hansoh Pharmaceutical.
JAMA Network Open · Jul 14, 2026
Errors in Table 1
In the Original Investigation titled “Measurement-Based Care to Enhance Antidepressant Treatment Outcomes in Major Depressive Disorder: A Randomized Clinical Trial” published on September 2, 2025, the values for annual participant and household income and time since diagnosis (median and IQR) reported in Table 1 were calculated using the SPSS “HAVERAGE” (weighted average/interpolated) method, but should have been calculated using simple non-interpolated methods. The values have been recalculated accordingly and the article has been corrected.
JAMA Network Open · Jul 14, 2026
Long-Term Physical Health Consequences of Child Maltreatment
Pediatrics
JAMA Network Open · Jul 14, 2026
Divergence in Menopause Symptom Narratives Between Online and Clinical Settings
This cross-sectional study investigates how menopause-related symptoms discussed in user-generated online posts compared with symptoms documented in electronic health record clinicial notes.
JAMA Network Open · Jul 14, 2026
Childhood Maltreatment and Adult Multimorbidity
This cohort study examines the associations between childhood maltreatment and adult multimorbidity using electronic health records for individuals in Hong Kong.
JAMA Network Open · Jul 14, 2026
Colorectal Cancer Treatment Delay Thresholds and Metastasis Risk
This cohort study of insured US patients with colorectal cancer undergoing curative-intent surgery examines the association of delays in treatment with metastasis.
JAMA Network Open · Jul 14, 2026
Preterm Child Health and Socioeconomic Factors in School Readiness and Achievement
This cohort study evaluates which early-life health and socioeconomic factors are associated with school readiness and educational attainment among children aged 5 to 7 years born very preterm in the UK.
JAMA Network Open · Jul 14, 2026
Hydrocodone vs Oxycodone and Postoperative Pain and Opioid Use in Joint Arthroplasty
This cohort study compares postoperative pain outcomes and opioid consumption for hydrocodone vs oxycodone among CYP2D6 normal metabolizers undergoing elective joint arthroplasty.
JAMA Network Open · Jul 14, 2026
Bevacizumab and Platinum Choice in Pembrolizumab-Treated Advanced Cervical Cancer
This comparative effectiveness study assesses how treatment combinations, including platinum choice and bevacizumab use, are associated with overall survival and serious adverse events in patients with advanced cervical cancer.
JAMA Network Open · Jul 14, 2026
Diagnosis-to-Ablation Time and Atrial Arrhythmia Recurrence After Ablation
This cohort study evaluates whether diagnosis-to-ablation time is associated with atrial arrhythmia recurrence following radiofrequency ablation for atrial fibrillation.
JAMA Network Open · Jul 14, 2026
Buprenorphine-Naloxone vs XR Naltrexone Following Opioid Withdrawal Treatment
This comparative effectiveness trial compares the association of buprenorphine-naloxone vs extended-release (XR) naltrexone treatment with reduction of all-cause mortality and nonfatal opioid overdose among patients who completed medically managed opioid withdrawal.
NHS England · Jul 13, 2026
NHS aims to prevent one in four sepsis deaths
The NHS will aim to prevent thousands of deaths from sepsis by 2035 as part of a series of measures to improve the treatment of the deadly condition. Sepsis is a life-threatening response to an infection in the body, which can cause significant damage to tissues and organs, and is estimated to cause around 4,000 […]
MedCity News · Jul 13, 2026
GSK Eyes FDA Filing After Immunotherapy Succeeds in Key Rectal Cancer Study
GSK drug Jemperli met the main goal of a pivotal Phase 2 test in patients with a rare type of rectal cancer, paving the way for regulatory submissions. This antibody drug has already received a voucher to speed up its review under a new FDA pilot program. The post GSK Eyes FDA Filing After Immunotherapy Succeeds in Key Rectal Cancer Study appeared first on MedCity News .
Fierce Biotech · Jul 13, 2026
CEPI-backed Ebola vaccine set to enter phase 1 trials
The first vaccine against the Bundibugyo ebola virus is poised to enter phase 1 clinical trial.
MedCity News · Jul 13, 2026
Nearly 200 Organizations Back Bill to Expand Access to Clinical Trials
Nearly 200 healthcare and patient advocacy organizations endorsed the bipartisan Clinical Trial Modernization Act, which seeks to reduce financial barriers and expand access to clinical trials for underrepresented patients. The post Nearly 200 Organizations Back Bill to Expand Access to Clinical Trials appeared first on MedCity News .